These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
493 related items for PubMed ID: 28879675
1. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy. Ecke TH, Stier K, Weickmann S, Zhao Z, Buckendahl L, Stephan C, Kilic E, Jung K. Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675 [Abstract] [Full Text] [Related]
2. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer. Jiang X, Du L, Duan W, Wang R, Yan K, Wang L, Li J, Zheng G, Zhang X, Yang Y, Wang C. Oncotarget; 2016 Jun 14; 7(24):36733-36742. PubMed ID: 27167342 [Abstract] [Full Text] [Related]
3. Tumor expression of miR-34a-3p is an independent predictor of recurrence in non-muscle-invasive bladder cancer and promising additional factor to improve predictive value of EORTC nomogram. Juracek J, Stanik M, Vesela P, Radova L, Dolezel J, Svoboda M, Slaby O. Urol Oncol; 2019 Mar 14; 37(3):184.e1-184.e7. PubMed ID: 30446443 [Abstract] [Full Text] [Related]
4. microRNA expression profile in a large series of bladder tumors: identification of a 3-miRNA signature associated with aggressiveness of muscle-invasive bladder cancer. Pignot G, Cizeron-Clairac G, Vacher S, Susini A, Tozlu S, Vieillefond A, Zerbib M, Lidereau R, Debre B, Amsellem-Ouazana D, Bieche I. Int J Cancer; 2013 Jun 01; 132(11):2479-91. PubMed ID: 23169479 [Abstract] [Full Text] [Related]
5. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome. Ratert N, Meyer HA, Jung M, Lioudmer P, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S, Jung K. J Mol Diagn; 2013 Sep 01; 15(5):695-705. PubMed ID: 23945108 [Abstract] [Full Text] [Related]
7. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH. Lancet Oncol; 2013 Dec 01; 14(13):1295-306. PubMed ID: 24239208 [Abstract] [Full Text] [Related]
8. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y. Gene; 2018 Oct 05; 673():181-193. PubMed ID: 29913239 [Abstract] [Full Text] [Related]
9. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer. An JX, Ma ZS, Ma MH, Shao S, Cao FL, Dai DQ. Cancer Biomark; 2019 Oct 05; 25(2):127-132. PubMed ID: 31045511 [Abstract] [Full Text] [Related]
10. The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer. Zhiyu Z, Qi Z, Zhen S, Jun O, Jianglei Z. Technol Cancer Res Treat; 2021 Oct 05; 20():15330338211062323. PubMed ID: 34816789 [Abstract] [Full Text] [Related]
11. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival. Xu Z, Yu YQ, Ge YZ, Zhu JG, Zhu M, Zhao YC, Xu LW, Yang XB, Geng LG, Dou QL, Jia RP. Tumour Biol; 2015 Sep 05; 36(10):8159-66. PubMed ID: 25990459 [Abstract] [Full Text] [Related]
12. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer. Zhang J, Zhou X, Ding H, Wang L, Liu S, Liu Y, Chen Z. BMC Urol; 2020 Mar 19; 20(1):31. PubMed ID: 32192483 [Abstract] [Full Text] [Related]